Insulet Corporation (PODD)

ISRG, PODD, BSX and IDXX lead medtech innovation with AI, robotics and diagnostics for growth in 2026....

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod brand of products, has announced ...

Geneos Wealth Management Inc. lowered its stake in shares of Insulet Corporation (NASDAQ: PODD) by 9.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securi...

Frontier Capital Management Co. LLC boosted its stake in Insulet Corporation (NASDAQ: PODD) by 3.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange C...

Insulet (PODD) is well positioned to outperform the market, as it exhibits above-average growth in financials....

Insulet Stock rises as the FDA clears key Omnipod 5 upgrades that enhance glucose targets and automation for its tubeless diabetes platform....

Brown Advisory Inc. cut its stake in Insulet Corporation (NASDAQ: PODD) by 20.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced i...

Fisher Asset Management LLC decreased its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 27.8% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fir...